Sanofi (SNY) Stock
SNY Key Statistics
About Sanofi
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. Within its Pharmaceutical segment, Sanofi delivers specialized therapies, including innovative human monoclonal antibodies, addressing complex conditions like multiple sclerosis, various neurological disorders, immunology and inflammatory diseases, oncology, rare diseases, and rare blood disorders. This segment also encompasses treatments for diabetes, cardiovascular health, and established prescription medications. Its Vaccine portfolio is extensive, offering essential immunizations such as pediatric vaccines for poliomyelitis, pertussis, and Hib, alongside influenza shots, adult boosters, meningitis vaccines, and solutions for travel and endemic diseases. The Consumer Healthcare division provides a broad spectrum of over-the-counter products, including remedies for allergies, coughs and colds, pain management, liver support, physical and mental wellness, probiotics, digestive health aids, and nutritional supplements. Additionally, it offers various personal care items like daily body lotions, anti-itch creams, moisturizing and soothing lotions, body and foot creams, and specialized powders for eczema. Sanofi maintains a robust development pipeline, with numerous pharmaceutical products and vaccines currently in various stages of research. The company actively pursues strategic alliances, exemplified by its collaboration with GlaxoSmithKline on a recombinant Covid-19 vaccine, a research partnership with Stanford University School of Medicine focused on advancing immunology and inflammation understanding, and a collaboration and license option agreement with Prellis Biologics, Inc. Founded in 1973 and headquartered in Paris, France, the company was formerly known as Sanofi-Aventis before officially changing its name to Sanofi in May 2011.
CEO: Belén Garijo López. Company website
SNY — Frequently Asked Questions
What is the SNY stock price today?
Sanofi (SNY) trades at $42.48, down 1.53% on the day, as of Sep 20, 2026 15:01 UTC.
What is Sanofi's market cap?
Sanofi has a market capitalisation of $102.00B, calculated from the live SNY share price and shares outstanding.
What is the P/E ratio of SNY?
SNY trades at a trailing P/E of 88.50, from earnings per share of $0.48 over the last twelve months.
How much revenue does Sanofi make?
Sanofi generated revenue of $48.92B over the trailing twelve months, which puts the stock at 2.09 times sales.
Does SNY pay a dividend?
Yes. Sanofi pays a dividend yielding 4.68% on the current share price.
What is the 52-week range for SNY?
SNY has traded between $40.89 and $52.68 over the past 52 weeks, and the last price is 19.4% below that high.
Is Sanofi profitable?
Yes. Sanofi keeps 8.09% of revenue as net income over the trailing twelve months.
What is the analyst price target for SNY?
Wall Street analysts rate SNY Hold, with an average price target of $49.50, 16.5% above the current price.
What sector is Sanofi in?
Sanofi is classified under the Healthcare sector and the Drug Manufacturers - General industry, and is domiciled in FR.
Who is the CEO of Sanofi?
Belén Garijo López is the chief executive of Sanofi, which employs 76,493 people.
Where can I track SNY in real time?
QFI Terminal shows SNY with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See SNY live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open SNY in Terminal See plans